- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Clinical translation

Our research aims to improve health outcomes. Clinical translation converts basic research discoveries into better ways to prevent, diagnose and treat disease. We are facilitating linkages between clinicians and laboratory researchers, and supporting clinical research.
Our clinical translation
We are committed to harnessing the talent of our researchers to deliver real healthcare improvements. Our Clinical Translation Centre fosters linkages between our laboratory researchers and clinicians.
Key aspects of our clinical translation program are:
- Supporting the involvement of clinician-scientists in our research programs, including through research training and education programs.
- Enabling our researchers’ involvement in the development, delivery and evaluation of clinical trials
- Facilitating the collection and analysis of human samples for approved research
More than 100 current clinical trials are based on discoveries made at WEHI.
What is clinical translation?
Clinical translation is research that leads to better understanding of disease, and/or development of new diagnostic tests or treatments.
Clinical translation may involve:
- Measuring the impact of a new strategy to prevent, treat or diagnose a disease in humans, using a clinical trial.
- Analysing human samples, such as those taken from people with a certain disease.
- Matching the genetic information (genome sequence) of a patient with features of their disease.
How do laboratory discoveries reach the clinic?
Many discoveries that have benefited the health of the community arose from basic laboratory research. Understanding how molecules, cells and tissues normally function gives insights into what goes wrong in disease.
Discovering how a disease develops can lead to new ways to prevent, treat and diagnose that disease. These are collectively called ‘interventions’.
Preclinical studies are used to test a proposed intervention in the laboratory, using patient samples or models that are similar to the diseased cells.
Clinical trials enable testing of the new intervention in people who have volunteered for the trial. Most clinical trials are conducted in stages:
Phase I: Tests the safety of the intervention in a small number of people, and whether the intervention works as intended.
Phase II: Determines how well the intervention can work.
Phase III: Uses a larger group of people to measure the overall benefits of the new intervention, comparing it with no intervention, or other existing interventions.
If an intervention shows success through all the stages of a clinical trial, it may then need government approval before it is available to the public. In Australia, the Therapeutic Goods Administration assesses the outcomes of clinical trials to approve new treatments, diagnostic tests or other interventions.
It often takes years or decades for a laboratory discovery to be translated into an improvement in healthcare. The successful outcomes of clinical trials requires:
- The intervention to be effective and improve health outcomes.
- Funding for the significant costs of conducting clinical trials. This is why many clinical trials are conducted with investment from pharmaceutical companies.
Who can participate in research?
Research participants are integral to clinical translation. These people must be:
- Willing to participate and able to attend a study or trial location.
- Fully informed about what their participation involves including any foreseeable risks.
- Aware of their rights to withdraw from the study.
- Eligible to participate in the study by meeting specified criteria, such as clinical diagnosis, medical history, or age.
Information about current clinical trials is available from:
- Your healthcare provider.
- Australian New Zealand Clinical Trials Registry.
- ClinicalTrials.gov, maintained by the US National Institutes of Health.
By joining the Volunteer Blood Donor Registry you can contribute to medical research aimed at preventing, treating and curing disease.
Governance of clinical translation
All research at WEHI that involves people is overseen by our Human Research Ethics Committee. The committee’s operation is approved by the National Health and Medical Research Council (NHMRC), and conforms to the NHMRC National Statement on Ethical Conduct in Research Involving Humans (2007).
Translational research at WEHI is facilitated by our Clinical Translation Standing Committee. This committee:
- Provides advice on translational and clinical research.
- Assists with the operation of the Clinical Translation Centre.
- Contributes to the recruitment and support of medically qualified researchers at WEHI.
Consumer involvement
Wherever possible, we aim to involve ‘consumers’ in our research. A consumer is a person who has been affected by a disease. They may have:
- Suffered the disease themselves or
- Cared for a family member or friend with the disease.
The conduct of medical research can be improved by considering consumers’ personal and professional experiences. This can:
- Strengthen medical research design.
- Improve the communication of results to the community.
- Ensure research addresses questions that are important for consumers.
- Educate researchers to understand their disease fully from a consumer point of view.
Our Consumer Advisory Panel has been established to better connect our research with community experiences of disease and consumer expectations.
Clinician-scientist training
WEHI offers specialised research training programs for clinicians and medical students. These include short-term placements as well as degree programs such as clinician PhD training. Learn more
Researchers:
Clinician scientists Associate Professor Jeanne Tie and Associate Professor Sumitra Ananda are leading trials of a blood test to guide cancer treatment after surgery.
Professor Andrew Roberts and collaborators have shown that patients with an advanced form of leukaemia can achieve complete remission with a novel tablet treatment.